PTEN induced putative kinase 1 (PINK1), also known as PARK6, is causally linked to familial Parkinsonism, and heterozygous loss of PINK1 is a risk factor for sporadic Parkinson’s disease. However, little is known about its physiological function. Its deficiency was shown to decrease dopamine without significant loss of dopaminergic neurons. We investigated the mechanistic basis for this observation in the present study using dopaminergic MN9D cells. We found that PINK1 knockdown resulted in dopamine content to decrease with suppressed tyrosine hydroxylase expression in cells. Conversely, PINK1 overexpression increased tyrosine hydroxylase protein level. We also found that PINK1 deficiency blocked the nuclear translocation and activity of nuclear receptor-related 1, a transcription factor regulating tyrosine hydroxylase gene expression. These data suggest that PINK1 regulates tyrosine hydroxylase gene expression and dopamine content by modulating the transcriptional activity of nuclear receptor-related 1. Taken together, our results reveal a novel function of PINK1 in dopamine homeostasis.
ValdesP and SchneiderBL (2016) Gene therapy: A promising approach for neuroprotection in Parkinson’s disease? , Front Neuroanat10, 123.
6.
AzzouzM, Martin-RendonE, BarberRD, MitrophanousKA, CarterEE, RohllJB, KingsmanSM, KingsmanAJ, MazarakisND (2002) Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson’s disease, J Neurosci22, 10302–10312.
CriscuoloC, VolpeG, De RosaA, VarroneA, MarongiuR, ManciniP, SalvatoreE, DallapiccolaB, FillaA, ValenteEM, De MicheleG (2006) PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism, Mov Disord21, 1265–1267.
9.
ValenteEM, SalviS, IalongoT, MarongiuR, EliaAE, CaputoV, RomitoL, AlbaneseA, DallapiccolaB, BentivoglioAR (2004) PINK1 mutations are associated with sporadic early-onset parkinsonism, Ann Neurol56, 336–341.
PilslA and WinklhoferKF (2012) Parkin, PINK1 and mitochondrial integrity: Emerging concepts of mitochondrial dysfunction in Parkinson’s disease, Acta Neuropathol123, 173–188.
12.
KohH, ChungJ (2012) PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity, Mol Cells34, 7–13.
13.
PrydeKR, SmithHL, ChauKY, SchapiraAH (2016) PINK1 disables the anti-fission machinery to segregate damaged mitochondria for mitophagy, J Cell Biol213, 163–171.
14.
MatsudaN, SatoS, ShibaK, OkatsuK, SaishoK, GautierCA, SouYS, SaikiS, KawajiriS, SatoF, KimuraM, KomatsuM, HattoriN, TanakaK (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy, J Cell Biol189, 211–221.
15.
OkatsuK, OkaT, IguchiM, ImamuraK, KosakoH, TaniN, KimuraM, GoE, KoyanoF, FunayamaM, Shiba-FukushimaK, SatoS, ShimizuH, FukunagaY, TaniguchiH, KomatsuM, HattoriN, MiharaK, TanakaK, MatsudaN (2012) PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria, Nat Commun3, 1016.
16.
HaqueME, ThomasKJ, D’SouzaC, CallaghanS, KitadaT, SlackRS, FraserP, CooksonMR, TandonA, ParkDS (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP, Proc Natl Acad Sci U S A105, 1716–1721.
17.
PridgeonJW, OlzmannJA, ChinLS, LiL (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. , e, PLoS Biol5, 172.
18.
Sanchez-MoraRM, ArboledaH, ArboledaG (2012) PINK1 overexpression protects against C2-ceramide-induced CAD cell death through the PI3K/AKT pathway, J Mol Neurosci47, 582–594.
19.
KitadaT, PisaniA, PorterDR, YamaguchiH, TscherterA, MartellaG, BonsiP, ZhangC, PothosEN, ShenJ (2007) Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice, Proc Natl Acad Sci U S A104, 11441–11446.
20.
WuYY, WangX, TanL, LiuD, LiuXH, WangQ, WangJZ, ZhuLQ (2013) Lithium attenuates scopolamine-induced memory deficits with inhibition of GSK-3beta and preservation of postsynaptic components, J Alzheimers Dis37, 515–527.
21.
JiangX, TianQ, WangY, ZhouXW, XieJZ, WangJZ, ZhuLQ (2011) Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C, J Neurochem118, 864–878.
22.
ShiHR, ZhuLQ, WangSH, LiuXA, TianQ, ZhangQ, WangQ, WangJZ (2008) 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner, J Neural Transm (Vienna)115, 879–888.
23.
LuL, ZhaoC, LiuY, SunX, DuanC, JiM, ZhaoH, XuQ, YangH (2005) Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson’s disease, Brain Res Brain Res Protoc15, 46–51.
24.
ChenY and DornGW (2013) PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria, Science340, 471–475.
25.
Harada, WuJ, HaycockJW, GoldsteinM (1996) Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressingwild-type and serine 40-substituted enzyme, J Neurochem67, 629–635.
26.
LindgrenN, XuZQ, LindskogM, Herrera-MarschitzM, GoinyM, HaycockJ, GoldsteinM, HökfeltT, FisoneG (2000) Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate NMDA receptors in rat striatum, J Neurochem74, 2470–2477.
27.
LiYH, GaoN, YeYW, LiX, YuS, YangH, UédaK, ChanP (2011) Alpha-synuclein functions as a negative regulator for expression of tyrosine hydroxylase, Acta Neurol Belg111, 130–135.
28.
LuL, SunX, LiuY, ZhaoH, ZhaoS, YangH (2012) DJ-1 upregulates tyrosine hydroxylase gene expression by activating its transcriptional factor Nurr1 via the ERK1/2 pathway, Int J Biochem Cell Biol44, 65–71.
29.
ZhongN, KimCY, RizzuP, GeulaC, PorterDR, PothosEN, SquitieriF, HeutinkP, XuJ (2006) DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor, J Biol Chem281, 20940–20948.
McWilliamsTG and MuqitMM (2017) PINK1 and Park, Emerging themes in mitochondrial homeostasis, Curr Opin Cell Biol45, 83–91.
35.
GlaslL, KloosK, GiesertF, RoethigA, Di BenedettoB, KühnR, ZhangJ, HafenU, ZerleJ, HofmannA, de AngelisMH, WinklhoferKF, HölterSM, Vogt WeisenhornDM, WurstW (2012) Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb, Exp Neurol235, 214–227.
36.
GispertS, RicciardiF, KurzA, AzizovM, HoepkenHH, BeckerD, VoosW, LeunerK, MüllerWE, KudinAP, KunzWS, ZimmermannA, RoeperJ, WenzelD, JendrachM, García-ArencíbiaM, Fernández-RuizJ, HuberL, RohrerH, BarreraM, ReichertAS, RübU, ChenA, NussbaumRL, AuburgerG (2009) Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration, PLoS One4, e5777.
37.
MailletA, KrainikA, DebûB, TroprèsI, LagrangeC, ThoboisS, PollakP, PintoS (2012) Levodopa effects on hand and speech movements in patients with Parkinson’s disease: A FMRI study, PLoS One7, e46541.
38.
SmithY, WichmannT, FactorSA, DeLongMR (2012) Parkinson’s disease therapeutics: Newdevelopments and challenges since the introduction of levodopa, Neuropsychopharmacology37, 213–246.
39.
BowlingKM, HuangZ, XuD, FerdousyF, FunderburkCD, KarnikN, NeckameyerW, O’DonnellJM (2008) Direct binding of GTP cyclohydrolase and tyrosine hydroxylase: Regulatory interactions between key enzymes in dopamine biosynthesis, J Biol Chem283, 31449–31459.
40.
CalvoAC, PeyAL, Miranda-VizueteA, Døskeland AP, MartinezA (2011) Divergence in enzyme regulation between Caenorhabditis elegans and human tyrosine hydroxylase, the key enzyme in the synthesis of dopamine, Biochem J434, 133–141.
41.
NakajimaA, KataokaK, HongM, SakaguchiM, HuhNH (2003) BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential, Cancer Lett201, 195–201.
42.
UnokiM and NakamuraY (2001) Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway, Oncogene20, 4457–4465.
43.
BeilinaA, Van Der BrugM, AhmadR, KesavapanyS, MillerDW, PetskoGA, CooksonMR (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability, Proc Natl Acad Sci U S A102, 5703–5708.
JacobsenKX, MacDonaldH, LemondeS, DaigleM, GrimesDA, BulmanDE, AlbertPR (2008) A Nurr1 point mutant, implicated in Parkinson’s disease, uncouples ERK1/2-dependent regulation of tyrosine hydroxylase transcription, Neurobiol Dis29, 117–122.
46.
ZhangT, JiaN, FeiE, WangP, LiaoZ, DingL, YanM, NukinaN, ZhouJ, WangG (2007) Nurr1 is phosphorylated by ERK2 in vitro and its phosphorylation upregulates tyrosine hydroxylase expression in SH-SY5Y cells, Neurosci Lett423, 118–122.
47.
EellsJB, MislerJA, NikodemVM (2006) Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice, Brain Res Bull70, 186–195.
48.
IwawakiT, KohnoK, KobayashiK (2000) Identification of a potential nurr1 response element that activates the tyrosine hydroxylase gene promoter in cultured cells, Biochem Biophys Res Commun274, 590–595.
49.
KimKS, KimCH, HwangDY, SeoH, ChungS, HongSJ, LimJK, AndersonT, IsacsonO (2003) Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner, J Neurochem85, 622–634.
50.
SakuradaK, Ohshima-SakuradaM, PalmerTD, GageFH (1999) Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain, Development126, 4017–4026.
51.
WuYC, CaiYQ, ZhaoYB, FeiJ (2006) Effects of Nurr1 down-regulation on the expression of tyrosine hydroxylase and neurite extension in dopaminergic cells, Sheng Li Xue Bao58, 351–358.
GaoN, LiYH, LiX, YuS, FuGL, ChenB (2007) Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene, Neurosci Bull23, 53–57.
54.
LuL, ZhaoS, GaoG, SunX, ZhaoH, YangH (2016) DJ-1/PARK7, but not its L166P mutant linked to autosomal recessive parkinsonism, modulates the transcriptional activity of the orphan nuclear receptor Nurr1 in vitro and in vivo, Mol Neurobiol53, 7363–7374.
